Company Overview

InRetail Perú Corp. is a Peru-based retail and consumer services holding company that operates across the food retail, pharmaceutical retail and distribution, and shopping center industries in Latin America, with its core market concentrated in Peru. The company is part of the broader Intercorp business group and is publicly traded on the New York Stock Exchange under the ticker INREF. Its principal revenue drivers are supermarket and discount retail operations, pharmacy chains, pharmaceutical distribution, and commercial real estate leasing tied to shopping malls.

The company’s primary operating platforms include InRetail Food, InRetail Pharma, and Real Plaza. Through these businesses, InRetail serves mass-market consumers, middle-income households, and healthcare-related commercial clients. The company has developed a strong competitive position in Peru through scale, nationwide distribution networks, vertically integrated pharmaceutical logistics, and a multi-format retail strategy that combines supermarkets, hard-discount stores, pharmacies, and shopping centers. InRetail evolved through a series of acquisitions and consolidations within the Intercorp ecosystem, including the expansion of supermarket operations and the acquisition of pharmaceutical distribution assets associated with Quicorp.

Business Operations

InRetail generates revenue through three principal operating segments: Food Retail, Pharma, and Shopping Malls. The Food Retail division is primarily operated through Supermercados Peruanos, which manages supermarket and discount banners including Plaza Vea, Vivanda, and Mass. This segment earns revenue from consumer grocery sales, private-label products, and high-volume discount retail operations. The company’s Pharma segment includes pharmacy chains such as Inkafarma and Mifarma, as well as pharmaceutical distribution and logistics operations inherited through Quicorp. The Shopping Malls segment operates through Real Plaza, one of Peru’s largest shopping center platforms.

The company’s operations are concentrated in Peru but include regional pharmaceutical distribution activities in other Latin American markets. InRetail controls extensive logistics infrastructure, retail real estate assets, distribution centers, and pharmacy networks that support integrated operations across its business lines. Strategic relationships within the Intercorp group strengthen customer reach and financial flexibility, while subsidiaries and affiliated businesses provide operational scale across retail, healthcare distribution, and commercial leasing activities.

Strategic Position & Investments

InRetail’s strategic direction has focused on expanding modern retail penetration in Peru, increasing the scale of discount retail formats, strengthening pharmaceutical distribution capabilities, and expanding shopping center infrastructure in underserved urban markets. The company has invested heavily in logistics modernization, digital retail channels, inventory optimization systems, and pharmacy network expansion. Its acquisition of Quicorp significantly expanded its pharmaceutical distribution footprint and reinforced vertical integration across the healthcare supply chain.

The company continues to prioritize high-frequency consumer categories such as groceries and healthcare products, which historically have shown resilient demand patterns. Real Plaza remains a strategic asset due to its integration with anchor retail tenants and consumer traffic generation. InRetail has also expanded e-commerce capabilities and omnichannel retail initiatives across grocery and pharmacy operations. Public disclosures and investor materials indicate continued investment in store expansion, technology platforms, and supply chain efficiency initiatives designed to improve operating margins and market share.

Geographic Footprint

InRetail is headquartered in Lima, Peru, and maintains its strongest operational presence throughout the Peruvian market. Its retail stores, pharmacies, logistics facilities, and shopping centers are distributed across major urban and regional markets in Peru, including Lima and secondary cities with growing middle-class consumer demand. The company’s supermarket, discount retail, and pharmacy formats are positioned to serve both densely populated metropolitan areas and emerging regional markets.

Through its pharmaceutical distribution operations, InRetail also maintains commercial exposure to other parts of Latin America, although Peru remains the dominant contributor to revenue and operating income. Its shopping center platform under Real Plaza has established a significant nationwide footprint, supporting both local retail tenants and international consumer brands. The company’s operational influence is strongest in the Andean region, with Peru serving as the central hub for management, logistics, and strategic investment activity.

Leadership & Governance

InRetail Perú Corp. operates within the broader governance framework of the Intercorp group, which was founded by Carlos Rodríguez-Pastor, a prominent Peruvian business executive associated with the expansion of financial services, education, healthcare, and retail businesses in Peru. The company’s leadership strategy has emphasized long-term consumer market growth, operational scale, disciplined capital allocation, and integrated retail ecosystems combining physical infrastructure with digital capabilities.

Key executives identified in recent public disclosures include:

• Carlos Rodríguez-Pastor – Founder and Chairman associated with the Intercorp group
• Rodolfo Orellana – Chief Executive Officer of InRetail Perú Corp.
• Carlos Saavedra – Chief Financial Officer
• Executives of Supermercados Peruanos, InRetail Pharma, and Real Plaza – Operational leadership roles across core business segments

Public filings and investor materials indicate that leadership has prioritized expansion in essential consumer sectors, technology-enabled retail operations, and long-term market penetration in Peru. Some executive role details may vary across reporting periods and subsidiary-level disclosures.